From unbearable side-effects to cravings curbed: readers on weight-loss jabs
Briefly

The promise of breakthrough drugs such as liraglutide and semaglutide to help people lose weight has been the subject of extensive media coverage in recent months, with Wegovy the latest such jab to be approved for use on the NHS for certain groups of people with obesity although it has yet to become available.
Read at www.theguardian.com
[
add
]
[
|
|
]